AZ SB1251

Prohibits manufacturers, repackagers, third-party logistics providers, wholesale distributors, and their agents or affiliates from denying, restricting, or limiting acquisition or delivery of 340B drugs to covered entities, contracted pharmacies, or authorized locations, except where prohibited by the U.S. Department of Health and Human Services.

Prohibits requiring 340B covered entities to submit claims or utilization data as a condition for drug acquisition or delivery, unless required by the U.S. Department of Health and Human Services.

Authorizes the State Board of Pharmacy to investigate violations and impose discipline, suspension, or revocation on permitted or licensed violators.

Makes violations subject to enforcement by the Attorney General as unlawful practices under section 44-1522, with each package of 340B drugs subject to a prohibited act constituting a separate violation.

Does not create a private right of action and does not restrict lawful limited distribution of drugs required under federal law or state law for controlled substances.